Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis
- PMID: 17549404
Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis
Abstract
c-Met is responsible for cell motility and tumour spreading. c-Met expression and signal transducers reflecting c-Met functionality were investigated in breast carcinomas, in correlation with patient outcome and tumour vasculature. Tissue microarrays of 930 breast carcinomas were constructed, categorised according to patients' follow-up (4- to 10-year follow-up; median, 6.5 years). Standardised immunocytochemical procedures were performed using anti-c-Met, -PI3K, -FAK, -JAK, and -CD146, -FYN and an automated autostainer (Ventana). High-throughput densitometry measuring the extent of immunoprecipitates was assessed by image analysis (SAMBA). c-Met overexpression correlated with poor survival along with PI3K and FAK reflecting c-Met functionality and CD146 and FYN expression in endothelial cells. Automated quantification of immunocytochemical precipitates using image analysis was shown to provide an objective means of measuring cellular proteins that are potentially relevant for current practice in pathological diagnosis and for specific therapy combining inhibitors of both c-Met and downstream transducer pathways, and of tumour angiogenesis.
Similar articles
-
Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.Hum Pathol. 2007 Jun;38(6):830-41. doi: 10.1016/j.humpath.2006.11.015. Epub 2007 Feb 20. Hum Pathol. 2007. PMID: 17316758
-
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays.Br J Cancer. 2007 Jan 29;96(2):329-35. doi: 10.1038/sj.bjc.6603569. Br J Cancer. 2007. PMID: 17242702 Free PMC article.
-
[High-throughput quantification of tissue microarrays: identification of candidate target proteins in inflammatory breast cancer].Bull Acad Natl Med. 2007 Feb;191(2):361-74; discussion 374-6. Bull Acad Natl Med. 2007. PMID: 17969554 Review. French.
-
Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.Hum Pathol. 2006 Jan;37(1):9-15. doi: 10.1016/j.humpath.2005.09.024. Hum Pathol. 2006. PMID: 16360410
-
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.Breast Cancer Res. 2005;7(2):R194-203. doi: 10.1186/bcr977. Epub 2005 Jan 7. Breast Cancer Res. 2005. PMID: 15743500 Free PMC article.
Cited by
-
Gene silencing of c-Met leads to brain metastasis inhibitory effects.Clin Exp Metastasis. 2013 Oct;30(7):845-54. doi: 10.1007/s10585-013-9584-7. Epub 2013 Apr 27. Clin Exp Metastasis. 2013. PMID: 23625089
-
Emerging targeted agents in metastatic breast cancer.Nat Rev Clin Oncol. 2013 Apr;10(4):191-210. doi: 10.1038/nrclinonc.2013.29. Epub 2013 Mar 5. Nat Rev Clin Oncol. 2013. PMID: 23459626 Review.
-
Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer.Genes Cancer. 2015 Jul;6(7-8):317-327. doi: 10.18632/genesandcancer.74. Genes Cancer. 2015. PMID: 26413215 Free PMC article.
-
Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A.Invest New Drugs. 2020 Oct;38(5):1365-1372. doi: 10.1007/s10637-020-00937-y. Epub 2020 Apr 22. Invest New Drugs. 2020. PMID: 32318883
-
Suppression of protein tyrosine phosphatase N23 predisposes to breast tumorigenesis via activation of FYN kinase.Genes Dev. 2017 Oct 1;31(19):1939-1957. doi: 10.1101/gad.304261.117. Epub 2017 Oct 24. Genes Dev. 2017. PMID: 29066500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous